ADM, The Every Company boost precision-fermented egg protein capacity fivefold
ADM and The Every Company are scaling production of OvoPro, an animal-free egg white protein, at ADM's Iowa facility, increasing US supply by five times from H2 2027.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
London, United Kingdom — 15 July 2026
ADM and The Every Company have announced a partnership to significantly scale the production of OvoPro, an animal-free egg white protein, utilising precision fermentation. Manufacturing will take place at ADM's facility in Clinton, Iowa, leveraging ADM's extensive fermentation infrastructure and The Every Company's proprietary technology. This collaboration is set to increase OvoPro volumes fivefold for the US market starting in the second half of 2027, addressing growing demand for alternative protein sources and mitigating volatility in traditional egg markets.
OvoPro functions as a direct egg or egg white replacer, offering critical binding, aeration, and gelling properties without off-notes or cholesterol, according to The Every Company. The ingredient also boasts a Protein Digestibility Corrected Amino Acid Score (PDCAAS) of 1.0. This makes it suitable for protein fortification in categories like baked goods (cookies, brownies, cakes, muffins), where it contributes structure and lift while enhancing protein content. Market research indicates that 31% of consumers consider protein when purchasing bread products, highlighting the commercial opportunity for such applications.
The partnership expands upon The Every Company's existing European production with Huvepharma, which currently supplies US customers including major retailers like Walmart and Target. ADM's involvement is strategic for The Every Company, offering a pathway for continued scaling within ADM's network as US demand escalates. This move also aligns with ADM's broader investment strategy in alternative proteins and sustainable ingredients.
For manufacturers, this collaboration offers a more stable and cost-competitive raw material alternative. The Every Company's CEO, Arturo Elizondo, notes that ADM's substantial facility size in Iowa will lead to competitive pricing for large-scale customers, providing cost-in-use savings by circumventing the price volatility inherent in traditional egg supplies. USDA data shows US retail egg prices fluctuated significantly, increasing 21.9% in 2025. The strategic intent is to bolster supply chain resilience and open new market avenues for agricultural outputs used in innovative biotechnological applications.
What this means for United States
US supplement and food manufacturers will gain significantly increased access to a consistent, price-stable precision-fermented egg white protein. This expanded supply, growing fivefold from H2 2027, enables reformulation strategies to replace volatile traditional egg ingredients, enhancing supply chain security. Brand owners can develop novel protein-fortified products, particularly in the sports nutrition and functional food sectors, leveraging OvoPro's PDCAAS 1.0 and functional properties. The competitive pricing facilitated by ADM's scale allows for potentially improved margins or more aggressive pricing strategies against competitors reliant on conventional eggs, presenting a clear competitive advantage in a market sensitive to pricing and ingredient stability.
For more on UK formulation and manufacturing best practice, learn more at Supplement Factory.